1887
Outbreaks Open Access
Like 0

Abstract

A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.6.2000094
2020-02-13
2020-09-30
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.6.2000094
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/6/eurosurv-25-6-4.html?itemId=/content/10.2807/1560-7917.ES.2020.25.6.2000094&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Novel coronavirus China. Disease outbreak news. Geneva: WHO; 2020. [Accessed: 4 Feb 2020]. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
  2. European Centre for Disease Prevention and Control (ECDC). Novel coronavirus. Stockholm: ECDC; 2020. [Accessed 12 Feb 2020]. Available from: https://www.ecdc.europa.eu/en/novel-coronavirus-china
  3. Haut Conseil de la santé publique (HCSP). Définition et classement des cas possibles et confirmés d’infection à MERS-CoV et précautions à mettre en œuvre lors de la prise en charge de ces patients. [Definition and classification of possible and confirmed cases of MERS-CoV infection and precautions to be taken when caring for these patients]. Paris: HCSP; 2015. Available from: https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=506
  4. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.  https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045  PMID: 31992387 
  5. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;S0140-6736(20)30154-9.  https://doi.org/10.1016/S0140-6736(20)30154-9  PMID: 31986261 
  6. World Health Organization (WHO). Go.Data: Managing complex data in outbreaks. Geneva: WHO. [Accessed: 4 Feb 2020]. Available from: https://www.who.int/godata
  7. European Centre for Disease Prevention and Control (ECDC). Public health management of persons having had contact with novel coronavirus cases in the European Union. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Public-health-management-contact-novel-coronavirus-cases-EU_0.pdf
  8. World Health Organization (WHO). The First Few X (FFX) Cases and contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection. Geneva: WHO; 2020. Available from: https://www.who.int/publications-detail/the-first-few-x-(ffx)-cases-and-contact-investigation-protocol-for-2019-novel-coronavirus-(2019-ncov)-infection
  9. European Centre for Disease Prevention and Control (ECDC). Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA). Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-guidelines-infectious-diseases-transmitted-aircraft-ragida-middle
  10. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;NEJMoa2001316.  https://doi.org/10.1056/NEJMoa2001316  PMID: 31995857 
  11. Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020:2020.01.25.919787.
  12. Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019-nCoV. bioRxiv. 2020:2020.01.23.917351.
  13. Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly C, Riley S, et al. Report 3: Transmissibility of 2019-nCoV. London: Imperial College London; 2020. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/
  14. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet; 2020: S0140-6736(20)30260-9.
  15. European Centre for Disease Prevention and Control (ECDC). Outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA – third update. 30 January 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-outbreak-acute-respiratory-syndrome-associated-novel-1#no-link
/content/10.2807/1560-7917.ES.2020.25.6.2000094
Loading

Data & Media loading...

Supplementary data

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error